Hospital AI Lab Practical information on medical AI for Irish hospitals

Updated:

Medical technology and research in Ireland

What is Ireland publishing and testing in medicine right now? This page collects papers whose author affiliations include Ireland and drug trials with sites there, all from the last 12 months, in three groups: surgical techniques, new drugs and therapies, and diseases.

Period: 2025-11-16 to 2026-11-16 · updated automatically every week

How to read this page
  • This is an automatic list of titles, journals, dates and links from PubMed and ClinicalTrials.gov. We do not copy abstracts or article text, and we have not checked the findings.
  • A paper or a trial existing is not evidence that a treatment works or is safe, and it is not medical advice. Ask your clinician about any treatment.
  • “Papers from Ireland” means at least one author affiliation mentions the country; it does not mean the whole study was done there.
  • Titles are shown in their original language (mostly English).

Surgical techniques

Minimally invasive, robot-assisted, endoscopic, joint replacement and transplant papers.

Showing the latest 12 of 450 matches

  1. Total Hip Arthroplasty versus Hemiarthroplasty for Displaced Fragility Femoral Neck Fractures in Older Adults: A Systematic Review and Meta-Analysis of Mortality, Reoperation, and Surgical Complications

    J Arthroplasty 2026-11-09 Pierce TP, Badawi JM, Alhammadi H et al. PMID 43003361

  2. Validation of Ontario criteria for patients transplanted with hepatocellular carcinoma

    HPB (Oxford) 2026-11-07 Magyar CTJ, Aceituno L, Zorigtbaatar A et al. PMID 42998952

  3. Pin-related complications in robotic-assisted total knee arthroplasty: a systematic review and meta-analysis of 15,874 knees

    J Robot Surg 2026-11-06 Ade-Conde M, Dhanoa D, Wolfstadt JI et al. PMID 42989037

  4. OSS: Open suturing skills vision-based assessment challenge 2024-2025

    Med Image Anal 2026-11-05 Hoffmann H, Bady S, Boer C et al. PMID 43019931

  5. Effective and ineffective teamwork in robotic-assisted surgery: operating room professionals' accounts

    Surg Endosc 2026-11-05 Nyein KP, Canady KM, Bingea DR et al. PMID 42988962

  6. BK polyomavirus viraemia after kidney transplantation: incidence, graft survival and its association with urinary tract malignancies

    J Nephrol 2026-11-05 Clince M, O'Donoghue D, Sandys V et al. PMID 42986224

  7. Inflammatory Markers Following Robotic-Assisted Versus Manual Total Knee Arthroplasty: A Systematic Review and Meta-Analysis

    J Arthroplasty 2026-11-02 Ade-Conde M, Son H, Lanting BA et al. PMID 42971445

  8. Frontiers in Biophotonics

    J Biomed Opt 2026-11-01 Komolibus K, Untracht GR, Andersson-Engels S et al. PMID 43022055

  9. Investigation of Torque Teno Virus Loads as a Marker of Immunosuppression in Pediatric Chronic Renal Failure: A Pilot Study

    Pediatr Transplant 2026-11-01 Kelly E, Awan A, Wildes D et al. PMID 42929496

  10. Selective NRF2 target induction despite falling NFE2L2 transcription across the MASLD spectrum: implications for marginal donor grafts and KEAP1-targeted therapy

    Free Radic Biol Med 2026-10-20 Campbell S, O'Reilly R, Ahmed O et al. PMID 42901279

  11. Performance evaluation of a novel size-based microfluidic platform for rare cell detection in blood and malignant effusions

    J Liq Biopsy 2026-10-16 Saini VM, Oner E, Cahill C et al. PMID 43032239

  12. How have management and outcomes of periprosthetic proximal femoral fractures changed? A comparison of two 8 year time periods in a high volume centre

    Injury 2026-10-15 Toner E, Madden-McKee C, Goodland C et al. PMID 42914721

New drugs and therapies (papers)

Phase 1–3 and randomized trials of drugs, antibodies, vaccines and new therapies.

Showing the latest 12 of 121 matches

  1. Extended Follow-up of Botensilimab plus Balstilimab in an Expanded Cohort of Microsatellite-Stable Metastatic Colorectal Cancer without Active Liver Metastases

    Clin Cancer Res 2026-11-02 Schlechter BL, Fakih MG, Tsimberidou AM et al. PMID 42663536

  2. An Internet-Based Cognitive-Behavioral Program, With Telephone Support, Improves Pain, Disability and Emotional Well-Being in Adults With Chronic Pain: Randomized Controlled Trial of the Pain Course With 2-Year Follow-Up

    Clin J Pain 2026-11-01 Navin C, Dear BF, Bisby MA et al. PMID 42528312

  3. First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial

    Lancet 2026-10-26 Slomovitz BM, Zhu J, Yin R et al. PMID 42933458

  4. Stepwise dual antiplatelet therapy de-escalation versus standard therapy for 12 months in patients with bifurcation lesions undergoing drug-coated balloon angioplasty: Insights from the REC-CAGEFREE II trial

    Int J Cardiol 2026-10-04 Yan Y, Wang Q, Liu Y et al. PMID 42830132

  5. Population Pharmacokinetics and Exposure-Response Analysis of Arpraziquantel Supporting Dose in Preschool-Aged Children Infected with Schistosoma

    Clin Pharmacol Drug Dev 2026-10-01 Brockhaus B, Mills R, Milenković-Grišić AM et al. PMID 42850922

  6. Petrelintide, a human amylin analogue for the treatment of obesity (ZUPREME 1): a randomised, double-blind, placebo-controlled, phase 2 trial

    Lancet Diabetes Endocrinol 2026-09-29 Garvey WT, Ard J, Connery L et al. PMID 42810355

  7. Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial

    Lancet 2026-09-29 Bellido V, le Roux CW, Ekinci EI et al. PMID 42810372

  8. Preclinical and clinical evaluation of systemic danegaptide for the treatment of nonproliferative diabetic retinopathy

    Sci Transl Med 2026-09-23 Hudson N, Porkoláb G, O'Callaghan J et al. PMID 42777083

  9. Pembrolizumab plus chemotherapy as first-line therapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: 4.5-year follow-up from the randomized phase III KEYNOTE-859 study

    ESMO Open 2026-09-16 Rha SY, Wyrwicz LS, Yañez P et al. PMID 42748509

  10. Prolozone M Therapy's Analgesic Efficacy for Managing Moderate-to-Severe Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial

    Pain Physician 2026-09-01 Niraj G, Charan N, Prabhu M et al. PMID 42804311

  11. Durvalumab and tremelimumab, with or without lenvatinib, combined with transarterial chemoembolisation in participants with embolisation-eligible hepatocellular carcinoma (EMERALD-3): a global, randomised, open-label, sponsor-blinded, phase 3 study

    Lancet Oncol 2026-09-01 Kudo M, Abou-Alfa GK, Ren Z et al. PMID 42636832

  12. Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2-associated high-risk HER2-negative early breast cancer: updated results from the OlympiA phase III trial

    Ann Oncol 2026-08-24 Garber JE, Cameron D, Campbell C et al. PMID 42636977

Drug trials started in the last year

Drug studies registered on ClinicalTrials.gov with a site in this country, newest first.

Showing the latest 12 of 39 matches

  1. A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

    NCT07541170 Phase: Phase 3 Started: 2026-10-06 Sponsor: Hoffmann-La Roche Conditions: Non-small Cell Lung Cancer Drug / intervention: Divarasib, Pembrolizumab

  2. A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.

    NCT07559175 Phase: Phase 2 Started: 2026-10-01 Sponsor: Aimmune Nestlé Health Science US R&D, LLC Conditions: Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality Drug / intervention: NHS7108, Zenpep®

  3. A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

    NCT07623161 Phase: Phase 3 Started: 2026-09-10 Sponsor: Takeda Conditions: Myelofibrosis, Anemia Drug / intervention: Placebo, Elritercept

  4. Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months

    NCT07507500 Phase: Phase 4 Started: 2026-09-02 Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz Conditions: Myocardial Infarction (MI) Drug / intervention: Prasugrel, Ticagrelor

  5. The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.

    NCT07559643 Phase: N/A Started: 2026-08-01 Sponsor: University College Dublin Conditions: Bariatric Surgery, Anti-Xa Activity, VTE (Venous Thromboembolism) Drug / intervention: Anti-Xa Activity Monitoring, Tinzaparin (Leo)

  6. A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

    NCT07492680 Phase: Phase 2 Started: 2026-07-27 Sponsor: Bristol-Myers Squibb Conditions: Solid Tumors Drug / intervention: Navlimetostat, Daraxonrasib

  7. Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests

    NCT07106632 Phase: Phase 3 Started: 2026-06-26 Sponsor: UNICANCER Conditions: Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast Cancer Drug / intervention: test-directed treatment: allocated treatment will depend on the PAM50 score result (centrally assessed) : chemo-endocrine therapy or endocrine therapy alone, In the control arm, the treatment will be as standard of care : chemo-endocrine therapy

  8. A Prospective, Open-label, Randomized, Multicenter Phase-III Trial to Evaluate the Efficacy of Pirtobrutinib and Epcoritamab Compared With R-(Mini)-CHOP for Treatment of Patients With DLBCL-type Richter Transformation

    NCT07917780 Phase: Phase 2 Started: 2026-06-18 Sponsor: German CLL Study Group Conditions: Richter Transformation Drug / intervention: Epcoritamab, Pirtobrutinib

  9. MAVRiC Studies 2L Treatment With AV in Patients With CLL/SLL Who Have Relapsed After a Course of BTKi + BCL2i Combination, With or Without Obinutuzumab

    NCT07024706 Phase: Phase 2 Started: 2026-06-04 Sponsor: AstraZeneca Conditions: Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Drug / intervention: Acalabrutinib, Venetoclax

  10. The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

    NCT06494878 Phase: Phase 3 Started: 2026-06-04 Sponsor: University of Calgary Conditions: Venous Thromboembolism, Postpartum Period, Aspirin Drug / intervention: Aspirin, Low-molecular-weight heparin

  11. A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions

    NCT07422480 Phase: Phase 3 Started: 2026-05-21 Sponsor: Takeda Conditions: Myelodysplastic Syndrome, Anemia Drug / intervention: Elritercept, Epoetin Alfa

  12. A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

    NCT07287098 Phase: Phase 2 Started: 2026-05-13 Sponsor: Eli Lilly and Company Conditions: Breast Neoplasms Drug / intervention: Imlunestrant, Goserelin

Diseases and population studies

Nationwide cohorts, registries and population-based studies on incidence and prevalence.

Showing the latest 12 of 1,548 matches

  1. Community-acquired pneumonia in Europe: heterogeneity, evidence gaps, and priorities for care

    Lancet Reg Health Eur 2026-11-07 Martin-Loeches I, Torres A PMID 43032774

  2. Artificial intelligence-enabled interventions for smoking cessation: a systematic review and meta-analysis of randomised controlled trials

    Int J Med Inform 2026-10-29 Adebisi YA, Alhur AA, Ogunkola IO et al. PMID 42970911

  3. Incidence of medically attended Lyme borreliosis across endemic regions of six European countries (BOLD): a prospective multicentre active surveillance study

    Lancet Reg Health Eur 2026-10-26 Halsby K, Loew-Baselli A, Moniuszko-Malinowska A et al. PMID 42990948

  4. Mucopolysaccharidosis (MPS) type VI: A case series to assess the efficacy of enzyme replacement therapy and to guide precision-based medicine in the IRISH paediatric cohort

    Mol Genet Metab Rep 2026-10-21 Mathew C, Carey N, Losty E et al. PMID 42959617

  5. Standardisation of stage information collected by European population-based cancer registries: an application to breast cancer survival

    ESMO Real World Data Digit Oncol 2026-10-20 Rossi S, Cerza F, Bennett D et al. PMID 42960025

  6. Residual risk in coronary artery disease: Identification of cardio-reno-metabolic and psychosocial phenotypes in a Latin American cohort of the INTERASPIRE registry

    Curr Probl Cardiol 2026-10-15 Perea J, Villarreal R, Elfman M et al. PMID 42880518

  7. Morphological and molecular characterisation of pathogenic helminths in common dolphins (Delphinus delphis) stranded along the Irish coast

    Int J Parasitol Parasites Wildl 2026-10-13 Guthruf S, Zintl A, Lawlor A et al. PMID 42953707

  8. Cardiometabolic diseases and prescription patterns in a Kuwait tertiary-care hospital: A retrospective cross-sectional chart review

    J Taibah Univ Med Sci 2026-10-12 Shehab M, AlSayegh A, AlOmar H et al. PMID 42903606

  9. A systematic and critical review of measurement scales for evaluating gastrointestinal symptoms during exercise

    J Int Soc Sports Nutr 2026-09-29 Aitkenhead R, Waldron M, Conway GE et al. PMID 42811668

  10. Helicobacter pylori eradication treatment dispensing in the Irish General Medical Services population from 2012 to 2022: a repeated cross-sectional analysis

    Int J Clin Pharm 2026-09-27 Dobrić M, Medina C, Bennett K et al. PMID 42801398

  11. The relationship between product-based creativity and ADHD traits in children and the associations with later well-being

    J Exp Child Psychol 2026-09-25 Fang H, Toivainen T, Greven CU et al. PMID 42790392

  12. Mapping population-based cancer registries in Europe: coverage, data availability, and capacity for real-world data generation

    ESMO Real World Data Digit Oncol 2026-09-22 Zadnik V, Duratović Konjević A, Jurtela M et al. PMID 42830857

Source: PubMed · ClinicalTrials.gov